Perindopril amlodipine tablets, known as Perindopril Amlodipine Tablets (III), and Boydine (generic name Felodipine Extended-Release Tablets) may be coadministered if necessary. Perindopril Amlodipine Tablets (III) is a combination of Perindopril Arginate and Amlodipine Benzenesulfonate, which is indicated for the treatment of people whose blood pressure cannot be effectively controlled by single-agent therapy, as well as as an alternative to both drugs at the same dose. Adverse drug reactions include dizziness, headache, drowsiness and palpitations. It should be contraindicated in people who are allergic to perindopril, amlodipine and other angiotensin-converting enzyme inhibitors (ACEIs), dihydropyridine derivatives, women in the first trimester of pregnancy, people with a previous history of ACEI-induced angioedema, people with hereditary or idiopathic angioedema or people with shock, severe aortic stenosis, severe hypotension, left ventricular outflow tract obstruction, and other conditions. Felodipine extended-release tablets are used in the treatment of hypertension, stable angina pectoris disease. It should be contraindicated in people who are allergic to the product, pregnant women, patients with conditions such as decompensated heart failure, unstable angina, acute myocardial infarction, and most often mild to moderate adverse reactions to ankle edema. The above two drugs can treat hypertension, hypertension treatment should be individualized, and the two drugs do not interact with each other, if necessary, can be taken at the same time under the guidance of a physician, not unauthorized use of drugs.